Visit our team at the 2018 DDW Digestive Disease Week!

Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world's largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Saturday, June 2nd - Tuesday, June 5th

Walter E. Washington Convention Center, Booth #616

Washington D.C.

Contact us to set up a meeting!

We will be featuring our ELISA kits for the measurement of biologics related to IBD and other diseases. Their brand name is ImmunoGuide®. The product range is covering the following parameters:

Infliximab, Etanercept, Adalimumab, Golimumab, Tocilizumab, Vedolizumab and Certolizumab Pegol

For the monitoring of these mAb drugs we are supplying quantitative ELISA test kits measuring the free drug concentration by using as a catcher:

• the target molecule (in most cases TNF-alpha)
• a highly specific mAb directed against the drug

In addition we are supplying ELISA testkits for the semi-quantitative determination of anti-drug antibodies generated by immunogenicity specifically measuring:

• the free anti-drug antibody concentration or alternatively
• the total anti-drug antibody concentration

Please visit our booth to speak with our experts about our support for clinical studies and/or scientific projects in the development and application of biologics in medical research.

View our Research Drug Monitoring page.